KAZIA THERAPEUTICS LTD Quarterly Entity Common Stock, Shares Outstanding from Q2 2018 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Kazia Therapeutics Ltd quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2018 to Q2 2024.
  • Kazia Therapeutics Ltd Entity Common Stock, Shares Outstanding for the quarter ending June 30, 2024 was 333M shares, a 46% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 333M +105M +46% Jun 30, 2024 20-F 2024-11-15
Q2 2023 228M +89.3M +64.3% Jun 30, 2023 20-F 2023-10-26
Q2 2022 139M +6.74M +5.11% Jun 30, 2022 20-F 2022-10-17
Q2 2021 132M +37.4M +39.6% Jun 30, 2021 20-F 2021-10-07
Q2 2020 94.6M +32.4M +52.2% Jun 30, 2020 20-F 2020-10-22
Q2 2019 62.2M +13.8M +28.4% Jun 30, 2019 20-F 2019-10-21
Q2 2018 48.4M Jun 30, 2018 20-F 2018-10-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.